logo

Ionis Pharmaceuticals Inc (IONS)



Trade IONS now with
  Date
  Headline
2/24/2021 7:16:39 AM Ionis Q4 Loss/Shr $2.44 Vs EPS $1.28 Last Year
12/8/2020 9:45:33 PM Ionis Pharmaceuticals Says Positioned For Strong 2021 And Beyond
11/13/2020 7:24:37 AM Ionis Pharma Reports Promising New Data For Antisense Medicine Targeting PCSK9 Presented At AHA
11/4/2020 7:31:51 AM Ionis Q3 Loss/shr $0.22 Vs. EPS $0.18 Prior Year
8/31/2020 6:56:39 AM Ionis To Buy Remaining 24% Of Common Stock Of Akcea It Does Not Already Own For $18.15/Shr Cash
8/13/2020 7:06:47 AM Akcea Announces New Pricing And Reimbursement Of WAYLIVRA In Germany
8/5/2020 7:13:03 AM Ionis Pharmaceuticals Q2 Net Loss $32 Mln Or $0.23/shr Vs. Net Loss $1 Mln Or $0.01/shr Last Year
6/9/2020 7:02:06 AM Akcea Appoints Kia Motesharei As New SVP, Business Development And Corporate Strategy
5/18/2020 7:01:59 AM Akcea Therapeutics Names Michael Price EVP And CFO
4/20/2020 7:06:07 AM Ionis And Partner Announce Enrollment Completion Of Global Phase 3 GENERATION HD1 Study For Huntington's Disease
2/26/2020 7:21:56 AM Ionis Q4 EPS $1.28 Vs $2.21 Last Year
1/22/2020 7:09:37 AM Akcea And Ionis Announce Positive Topline Phase 2 Results Of AKCEA-APOCIII-L Rx
1/10/2020 7:02:55 AM Akcea And Ionis Begin CARDIO-TTRansform Phase 3 Clinical Trial For AKCEA-TTR-LRx
1/9/2020 7:06:20 AM Ionis Pharmaceuticals Appoints Onaiza Cadoret-Manier As Chief Corporate Development And Commercial Officer